Rapt Therapeutics shares owned by UBS Group
Historical chart of UBS Group investment in Rapt Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapt Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapt Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.2M | 90k | 24.85 |
| 2023-09-30 | $570k | 34k | 16.62 |
| 2023-06-30 | $886k | 47k | 18.70 |
| 2023-03-31 | $896k | 49k | 18.35 |
| 2022-12-31 | $2.0M | 100k | 19.80 |
| 2022-09-30 | $279k | 12k | 24.20 |
| 2022-06-30 | $49k | 2.7k | 18.21 |
| 2022-03-31 | $1.0M | 45k | 22.45 |
| 2021-12-31 | $2.9M | 78k | 36.69 |
| 2021-09-30 | $193k | 6.2k | 30.99 |
| 2021-06-30 | $196k | 6.2k | 31.66 |
| 2021-03-31 | $199k | 9.0k | 22.15 |
| 2020-12-31 | $152k | 8.1k | 18.74 |
| 2020-09-30 | $626k | 19k | 32.22 |
| 2020-06-30 | $451k | 16k | 28.98 |
| 2020-03-31 | $34k | 1.6k | 21.26 |
| 2019-12-31 | $82k | 2.9k | 28.00 |